Car-T Central
  • CAR-T Fundamentals
  • CAR-T in Australia
  • Clinical Management
  • Expert Opinion
  • About Us
  • Register
Car-T Central
  • CAR-T Fundamentals
  • CAR-T in Australia
  • Clinical Management
  • Expert Opinion
  • About Us
  • Register

ciltacabtagene autoleucel

All EHA CAR-T Abstracts

Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]

CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, A B-Cell Maturation Antigen Directed Chimeric Antigen Receptor T cell Therapy, in Relapsed/Refractory Multiple Myeloma.

Preliminary results indicate  that anti-BCMA CAR-T cell therapy, ciltacabtagene autleucel (cilta-cel), resulted in early, deep and durable responses in heavily pre-treated patients with MM.   ORR was , sCR .  Durability […]

Privacy Policy © Copyright Bastion Brands 2022